ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105509 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105509; 2) Community: the network communities that were significantly associated with the response to NSC 105509; 3) Molecule: the relationships between components within communities and NSC 105509; 4) MDR: the compounds that were significantly associated with the NSC 105509.

NSC Compound Enrichment Correlation
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0228801759885691 -0.25629174
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0228801759885691 -0.10511173
NSC 733504 Everolimus 0.0228801759885691 0.30871122
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.0228801759885691 -0.15926221
NSC 740 Methotrexate 0.0228801759885691 -0.19576035
NSC 67041 Null 0.0238174255956144 -0.086599616
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.0238174255956146 -0.20875802
NSC 641245 Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- 0.0238174255956146 -0.0062275996
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 0.0238174255956146 0.29132952
NSC 677640 Null 0.0238174255956146 0.37005806
Total:57  Current:26    [First] [Prev] [Next] [Last]